Brg1 governs distinct pathways to direct multiple aspects of mammalian neural crest cell development

Division of Cardiovascular Medicine, Department of Medicine, Department of Chemical and Systems Biology, and Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 01/2013; 110(5). DOI: 10.1073/pnas.1218072110
Source: PubMed


Development of the cerebral vessels, pharyngeal arch arteries (PAAs). and cardiac outflow tract (OFT) requires multipotent neural crest cells (NCCs) that migrate from the neural tube to target tissue destinations. Little is known about how mammalian NCC development is orchestrated by gene programming at the chromatin level, however. Here we show that Brahma-related gene 1 (Brg1), an ATPase subunit of the Brg1/Brahma-associated factor (BAF) chromatin-remodeling complex, is required in NCCs to direct cardiovascular development. Mouse embryos lacking Brg1 in NCCs display immature cerebral vessels, aberrant PAA patterning, and shortened OFT. Brg1 suppresses an apoptosis factor, Apoptosis signal-regulating kinase 1 (Ask1), and a cell cycle inhibitor, p21(cip1), to inhibit apoptosis and promote proliferation of NCCs, thereby maintaining a multipotent cell reservoir at the neural crest. Brg1 also supports Myosin heavy chain 11 (Myh11) expression to allow NCCs to develop into mature vascular smooth muscle cells of cerebral vessels. Within NCCs, Brg1 partners with chromatin remodeler Chromodomain-helicase-DNA-binding protein 7 (Chd7) on the PlexinA2 promoter to activate PlexinA2, which encodes a receptor for semaphorin to guide NCCs into the OFT. Our findings reveal an important role for Brg1 and its downstream pathways in the survival, differentiation, and migration of the multipotent NCCs critical for mammalian cardiovascular development.

Full-text preview

Available from:
  • Source
    • "miRNAs), have been implicated in different steps of neural crest development in various species (Liu and Xiao, 2011;Prasad et al., 2012;StroblMazzulla et al., 2012;Mayanil, 2013). For example, it has been shown that the histone H3K9me3/H3K36me3 demethylase JmjD2A regulates neural crest specification in the chick (StroblMazzulla et al., 2010), and the PRC1 component Ring1b specifically modulates craniofacial chondrocyte differentiation in zebrafish without affecting early induction and migration of the neural crest (van derVelden et al., 2013Eroglu et al., 2006;Bajpai et al., 2010;Weider et al., 2012;Li et al., 2013). Furthermore, both microRNA-processing enzymes and several specific microRNAs have been shown to regulate neural crest migration or affect neural crest-derived tissues, such as cranial and cardiovascular structures (Prasad et al., 2012;Strobl-Mazzulla et al., 2012;Mayanil, 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Neural crest cells arise from the border of the neural plate and epidermal ectoderm, migrate extensively and differentiate into diverse cell types during vertebrate embryogenesis. Although much has been learnt about growth factor signals and gene regulatory networks that regulate neural crest development, limited information is available on how epigenetic mechanisms control this process. In this study, we show that Polycomb repressive complex 2 (PRC2) cooperates with the transcription factor Snail2/Slug to modulate neural crest development in Xenopus. The PRC2 core components Eed, Ezh2 and Suz12 are expressed in the neural crest cells and are required for neural crest marker expression. Knockdown of Ezh2, the catalytic subunit of PRC2 for histone H3K27 methylation, results in defects in neural crest specification, migration and craniofacial cartilage formation. EZH2 interacts directly with Snail2, and Snail2 fails to expand the neural crest domains in the absence of Ezh2. Chromatin immunoprecipitation analysis shows that Snail2 regulates EZH2 occupancy and histone H3K27 trimethylation levels at the promoter region of the Snail2 target E-cadherin. Our results indicate that Snail2 cooperates with EZH2 and PRC2 to control expression of the genes important for neural crest specification and migration during neural crest development. © 2015. Published by The Company of Biologists Ltd.
    Full-text · Article · Jan 2015 · Development
  • Source
    • "Patients with hereditary cerebral amyloidosis were found to develop severe CAA, along with hemorrhagic strokes and vascular dementia due to SMC degeneration (Fossati et al., 2010). On the other hand, the differences in apolipoprotein E (APOE) genotypes seem to have notable effect on the course of sporadic CAA as SMCs can internalize Ab via the lipoprotein pathway involving APOE (Ruzali et al., 2013). Carrier of APOE4 showed increased incidence of Ab accumulation, rendering the vessel walls more prone to vasculopathic rupture (Strittmatter et al., 1993; Schmechel et al., 1993; Mazur-Kolecka et al., 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is growing recognition of cerebrovascular contributions to neurodegenerative diseases. In the walls of cerebral arteries, amyloid-beta (Aβ) accumulation is evident in a majority of aged people and patients with cerebral amyloid angiopathy. Here, we leverage human pluripotent stem cells to generate vascular smooth muscle cells (SMCs) from neural crest progenitors, recapitulating brain-vasculature-specific attributes of Aβ metabolism. We confirm that the lipoprotein receptor, LRP1, functions in our neural-crest-derived SMCs to mediate Aβ uptake and intracellular lysosomal degradation. Hypoxia significantly compromises the contribution of SMCs to Aβ clearance by suppressing LRP1 expression. This enabled us to develop an assay of Aβ uptake by using the neural crest-derived SMCs with hypoxia as a stress paradigm. We then tested several vascular protective compounds in a high-throughput format, demonstrating the value of stem-cell-based phenotypic screening for novel therapeutics and drug repurposing, aimed at alleviating amyloid burden.
    Full-text · Article · Oct 2014 · Cell Reports
    • "On the other hand, any selective cell death was not found in these treatments. In mouse neural crest cells, it has been shown that BRG1, the catalytic subunit of SWI/ SNF-B, suppresses the apoptosis and promotes the proliferation (Li et al., 2013). Thus, the maintenance of the undifferentiated state of the trunk neural crest cells may be due to the promotion of the proliferation of the undifferentiated neural crest cells by BMP/Wnt signaling and the chromatin remodelers. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We analyzed roles of two chromatin remodelers, Chromodomain Helicase DNA-binding protein 7 (CHD7) and SWItch/Sucrose NonFermentable-B (SWI/SNF-B), and Bone Morphogenetic Protein (BMP)/Wnt signaling in the maintenance of the multipotency of mouse trunk neural crest cells, leading to the formation of mouse neural crest-derived stem cells (mouse NCSCs). CHD7 was expressed in the undifferentiated neural crest cells and in the dorsal root ganglia (DRG) and sciatic nerve, typical tissues containing NCSCs. BMP/Wnt signaling stimulated the expression of CHD7 and participated in maintaining the multipotency of neural crest cells. Furthermore, the promotion of CHD7 expression maintained the multipotency of these cells. The inhibition of CHD7 and SWI/SNF-B expression significantly suppressed the maintenance of the multipotency of these cells. In addition, BMP/Wnt treatment promoted CHD7 expression and caused the increase of the percentage of multipotent cells in DRG. Thus, the present data suggest that the chromatin remodelers as well as BMP/Wnt signaling play essential roles in the maintenance of the multipotency of mouse trunk neural crest cells and in the formation of mouse NCSCs.
    No preview · Article · May 2014 · Mechanisms of Development
Show more